| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroprotective Agents | 19 | 2018 | 956 | 3.890 |
Why?
|
| Amyotrophic Lateral Sclerosis | 15 | 2017 | 1436 | 2.670 |
Why?
|
| Hypoxia-Ischemia, Brain | 6 | 2017 | 343 | 1.960 |
Why?
|
| Melatonin | 6 | 2018 | 666 | 1.620 |
Why?
|
| Spinal Cord | 8 | 2015 | 1804 | 1.540 |
Why?
|
| Serotonin | 4 | 2018 | 1032 | 1.440 |
Why?
|
| Receptor, Melatonin, MT1 | 4 | 2018 | 30 | 1.180 |
Why?
|
| Apoptosis | 25 | 2018 | 9429 | 1.000 |
Why?
|
| Methazolamide | 3 | 2016 | 9 | 0.990 |
Why?
|
| Frizzled Receptors | 3 | 2014 | 90 | 0.970 |
Why?
|
| Wnt Proteins | 3 | 2013 | 720 | 0.960 |
Why?
|
| SOX9 Transcription Factor | 4 | 2018 | 145 | 0.960 |
Why?
|
| Cell Death | 14 | 2015 | 1664 | 0.920 |
Why?
|
| Cytochromes c | 7 | 2015 | 173 | 0.910 |
Why?
|
| Superoxide Dismutase | 8 | 2015 | 586 | 0.870 |
Why?
|
| Tryptophan | 2 | 2015 | 484 | 0.860 |
Why?
|
| Mitochondria | 13 | 2015 | 3556 | 0.850 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2017 | 494 | 0.790 |
Why?
|
| Huntington Disease | 5 | 2011 | 1134 | 0.750 |
Why?
|
| HMGB1 Protein | 2 | 2014 | 139 | 0.710 |
Why?
|
| Brain Ischemia | 7 | 2018 | 3127 | 0.650 |
Why?
|
| Neurons | 14 | 2017 | 9353 | 0.650 |
Why?
|
| Neural Stem Cells | 3 | 2017 | 876 | 0.640 |
Why?
|
| MicroRNAs | 5 | 2018 | 3766 | 0.640 |
Why?
|
| Caspase 1 | 4 | 2009 | 226 | 0.630 |
Why?
|
| Infarction, Middle Cerebral Artery | 4 | 2017 | 481 | 0.630 |
Why?
|
| Caspases | 10 | 2015 | 879 | 0.620 |
Why?
|
| Astrocytes | 5 | 2017 | 1318 | 0.620 |
Why?
|
| Cytoprotection | 2 | 2014 | 200 | 0.560 |
Why?
|
| Wnt1 Protein | 2 | 2014 | 120 | 0.550 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2006 | 44 | 0.540 |
Why?
|
| Caspase 3 | 8 | 2016 | 729 | 0.540 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2016 | 125 | 0.530 |
Why?
|
| Disease Models, Animal | 21 | 2017 | 17958 | 0.530 |
Why?
|
| Hydrogen Peroxide | 3 | 2014 | 727 | 0.530 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2017 | 288 | 0.530 |
Why?
|
| Motor Neurons | 3 | 2015 | 849 | 0.520 |
Why?
|
| Pemphigus | 3 | 2006 | 115 | 0.490 |
Why?
|
| Brain Edema | 2 | 2016 | 595 | 0.490 |
Why?
|
| Substantia Nigra | 1 | 2016 | 349 | 0.480 |
Why?
|
| Cerebellar Nuclei | 1 | 2014 | 51 | 0.470 |
Why?
|
| Hemin | 1 | 2014 | 49 | 0.470 |
Why?
|
| Brain Injuries | 2 | 2018 | 1967 | 0.460 |
Why?
|
| Animals | 55 | 2019 | 166811 | 0.450 |
Why?
|
| Mice, Transgenic | 12 | 2017 | 9467 | 0.440 |
Why?
|
| Globins | 1 | 2014 | 403 | 0.440 |
Why?
|
| Nerve Tissue Proteins | 6 | 2017 | 4412 | 0.430 |
Why?
|
| Keratinocytes | 4 | 2004 | 787 | 0.420 |
Why?
|
| Oxidative Stress | 5 | 2018 | 3050 | 0.410 |
Why?
|
| Carbonic Anhydrase Inhibitors | 2 | 2009 | 91 | 0.400 |
Why?
|
| Muscular Atrophy | 1 | 2014 | 326 | 0.390 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2014 | 298 | 0.380 |
Why?
|
| Antioxidants | 5 | 2013 | 1651 | 0.380 |
Why?
|
| Mice | 33 | 2019 | 80550 | 0.370 |
Why?
|
| Central Nervous System Agents | 1 | 2011 | 72 | 0.370 |
Why?
|
| Autophagy | 3 | 2017 | 1324 | 0.360 |
Why?
|
| Parkinsonian Disorders | 1 | 2013 | 284 | 0.350 |
Why?
|
| Neuroglia | 2 | 2015 | 940 | 0.350 |
Why?
|
| Drug Design | 1 | 2015 | 1058 | 0.350 |
Why?
|
| Liver Diseases | 1 | 2018 | 1276 | 0.350 |
Why?
|
| Blotting, Western | 9 | 2019 | 5035 | 0.340 |
Why?
|
| Stroke | 5 | 2018 | 9879 | 0.340 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 769 | 0.330 |
Why?
|
| Reperfusion Injury | 2 | 2013 | 1004 | 0.330 |
Why?
|
| Membrane Potential, Mitochondrial | 5 | 2014 | 296 | 0.330 |
Why?
|
| Osteoporosis | 1 | 2018 | 1589 | 0.320 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 1025 | 0.320 |
Why?
|
| Cells, Cultured | 12 | 2017 | 18915 | 0.310 |
Why?
|
| Gene Expression Regulation | 6 | 2017 | 11884 | 0.310 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2019 | 8157 | 0.310 |
Why?
|
| Acantholysis | 2 | 2006 | 11 | 0.310 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2009 | 113 | 0.310 |
Why?
|
| Stem Cell Transplantation | 2 | 2017 | 1600 | 0.300 |
Why?
|
| Autoantibodies | 3 | 2006 | 2076 | 0.290 |
Why?
|
| Hypothermia, Induced | 1 | 2012 | 752 | 0.290 |
Why?
|
| Neurogenesis | 1 | 2014 | 847 | 0.290 |
Why?
|
| Corpus Striatum | 1 | 2013 | 1220 | 0.280 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1480 | 0.280 |
Why?
|
| Cell Proliferation | 7 | 2018 | 10360 | 0.280 |
Why?
|
| beta Catenin | 1 | 2012 | 1041 | 0.280 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 1267 | 0.280 |
Why?
|
| Stem Cells | 4 | 2017 | 3523 | 0.280 |
Why?
|
| Neural Tube Defects | 1 | 2009 | 253 | 0.280 |
Why?
|
| Signal Transduction | 13 | 2019 | 23234 | 0.270 |
Why?
|
| Ribosomal Proteins | 1 | 2009 | 359 | 0.270 |
Why?
|
| Neurodegenerative Diseases | 4 | 2011 | 1065 | 0.270 |
Why?
|
| Enzyme Activation | 8 | 2014 | 3597 | 0.270 |
Why?
|
| Caspase 9 | 4 | 2014 | 186 | 0.270 |
Why?
|
| Chloride Channels | 2 | 2019 | 218 | 0.270 |
Why?
|
| Cognition Disorders | 2 | 2019 | 3970 | 0.260 |
Why?
|
| Deep Brain Stimulation | 1 | 2014 | 801 | 0.260 |
Why?
|
| Ischemia | 1 | 2014 | 1875 | 0.250 |
Why?
|
| Oxidopamine | 2 | 2016 | 171 | 0.250 |
Why?
|
| Immunohistochemistry | 9 | 2019 | 11008 | 0.250 |
Why?
|
| Receptor, Melatonin, MT2 | 2 | 2018 | 81 | 0.240 |
Why?
|
| Receptors, Neurokinin-1 | 2 | 2015 | 128 | 0.240 |
Why?
|
| Carrier Proteins | 5 | 2008 | 4931 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1649 | 0.240 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2016 | 371 | 0.230 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2015 | 1346 | 0.220 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2013 | 613 | 0.220 |
Why?
|
| Sleep | 1 | 2018 | 4687 | 0.210 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 2085 | 0.210 |
Why?
|
| Glioma | 4 | 2018 | 3395 | 0.210 |
Why?
|
| Minocycline | 1 | 2003 | 169 | 0.200 |
Why?
|
| Epidermis | 2 | 2004 | 521 | 0.200 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3359 | 0.190 |
Why?
|
| Cell Survival | 4 | 2016 | 5771 | 0.190 |
Why?
|
| Bromodeoxyuridine | 3 | 2017 | 310 | 0.190 |
Why?
|
| Endoplasmic Reticulum | 2 | 2006 | 1119 | 0.190 |
Why?
|
| Transfection | 5 | 2016 | 5780 | 0.180 |
Why?
|
| Blood-Brain Barrier | 2 | 2017 | 1014 | 0.180 |
Why?
|
| Membrane Potentials | 2 | 2017 | 1096 | 0.180 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2001 | 197 | 0.180 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2016 | 1078 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 17647 | 0.170 |
Why?
|
| Down-Regulation | 3 | 2017 | 2910 | 0.170 |
Why?
|
| Hippocampus | 3 | 2017 | 3706 | 0.160 |
Why?
|
| Brain | 5 | 2014 | 26659 | 0.160 |
Why?
|
| Receptors, Melatonin | 1 | 2018 | 31 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 7 | 2017 | 21717 | 0.160 |
Why?
|
| Rats | 7 | 2017 | 23563 | 0.150 |
Why?
|
| Cell Differentiation | 4 | 2017 | 11425 | 0.150 |
Why?
|
| Membrane Transport Modulators | 1 | 2017 | 24 | 0.150 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 3 | 2006 | 32 | 0.150 |
Why?
|
| Liver | 1 | 2013 | 7426 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 66 | 0.150 |
Why?
|
| Nortriptyline | 2 | 2008 | 79 | 0.150 |
Why?
|
| Hexokinase | 1 | 2017 | 125 | 0.150 |
Why?
|
| Dynamins | 1 | 2017 | 139 | 0.140 |
Why?
|
| Cerebral Cortex | 6 | 2017 | 5697 | 0.140 |
Why?
|
| Sympatholytics | 1 | 2016 | 82 | 0.140 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5785 | 0.140 |
Why?
|
| Interleukin-1beta | 2 | 2015 | 996 | 0.140 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 3 | 2006 | 139 | 0.140 |
Why?
|
| Apoptosis Inducing Factor | 2 | 2014 | 51 | 0.140 |
Why?
|
| Time Factors | 8 | 2014 | 39846 | 0.140 |
Why?
|
| Pyramidal Cells | 1 | 2019 | 367 | 0.140 |
Why?
|
| Cell Line | 6 | 2019 | 15634 | 0.130 |
Why?
|
| Dendrites | 1 | 2019 | 476 | 0.130 |
Why?
|
| Brain Neoplasms | 4 | 2018 | 8892 | 0.130 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 3668 | 0.130 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 3447 | 0.130 |
Why?
|
| Up-Regulation | 3 | 2014 | 4114 | 0.130 |
Why?
|
| Hybrid Cells | 1 | 2015 | 422 | 0.130 |
Why?
|
| Enkephalin, Leucine | 1 | 2014 | 15 | 0.130 |
Why?
|
| Angiopoietin-1 | 1 | 2015 | 122 | 0.130 |
Why?
|
| Dacarbazine | 1 | 2018 | 560 | 0.120 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2014 | 53 | 0.120 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2014 | 44 | 0.120 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 546 | 0.120 |
Why?
|
| HeLa Cells | 3 | 2006 | 3087 | 0.120 |
Why?
|
| Neurotensin | 1 | 2014 | 57 | 0.120 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 248 | 0.120 |
Why?
|
| Stereoisomerism | 1 | 2015 | 623 | 0.120 |
Why?
|
| Humans | 38 | 2018 | 752411 | 0.120 |
Why?
|
| Posterior Horn Cells | 1 | 2014 | 90 | 0.120 |
Why?
|
| Vasospasm, Intracranial | 1 | 2016 | 210 | 0.120 |
Why?
|
| Substance P | 1 | 2015 | 334 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 434 | 0.120 |
Why?
|
| RNA, Messenger | 4 | 2016 | 12739 | 0.110 |
Why?
|
| Male | 25 | 2019 | 354908 | 0.110 |
Why?
|
| Lateral Ventricles | 1 | 2014 | 143 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2014 | 160 | 0.110 |
Why?
|
| Malondialdehyde | 1 | 2013 | 104 | 0.110 |
Why?
|
| Riluzole | 1 | 2013 | 58 | 0.110 |
Why?
|
| Neuronavigation | 1 | 2014 | 165 | 0.110 |
Why?
|
| Medulla Oblongata | 1 | 2014 | 245 | 0.110 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 387 | 0.110 |
Why?
|
| Prediabetic State | 1 | 2019 | 529 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 1873 | 0.110 |
Why?
|
| Subcellular Fractions | 1 | 2014 | 531 | 0.110 |
Why?
|
| Gene Expression Profiling | 3 | 2013 | 9356 | 0.110 |
Why?
|
| Biological Assay | 1 | 2016 | 631 | 0.110 |
Why?
|
| Nerve Fibers | 1 | 2016 | 705 | 0.100 |
Why?
|
| DNA Fragmentation | 2 | 2004 | 237 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 1092 | 0.100 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 329 | 0.100 |
Why?
|
| Dipyrone | 1 | 2011 | 9 | 0.100 |
Why?
|
| Aspartate Aminotransferases | 1 | 2013 | 412 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2014 | 1125 | 0.100 |
Why?
|
| Permeability | 1 | 2014 | 719 | 0.100 |
Why?
|
| Mutation | 3 | 2013 | 29706 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2018 | 2605 | 0.100 |
Why?
|
| Postmortem Changes | 1 | 2011 | 119 | 0.100 |
Why?
|
| Choline | 1 | 2013 | 512 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2013 | 489 | 0.100 |
Why?
|
| Lentivirus | 1 | 2014 | 494 | 0.100 |
Why?
|
| Creatine | 1 | 2013 | 424 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 501 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 1945 | 0.090 |
Why?
|
| Aspartic Acid | 1 | 2013 | 575 | 0.090 |
Why?
|
| Oncogenes | 1 | 2016 | 1215 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 432 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4571 | 0.090 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 210 | 0.090 |
Why?
|
| Embryo, Mammalian | 2 | 2017 | 1663 | 0.090 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 13410 | 0.090 |
Why?
|
| Cell Movement | 3 | 2017 | 5172 | 0.090 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 1424 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 3703 | 0.090 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2009 | 414 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2015 | 1310 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 1989 | 0.090 |
Why?
|
| Cell Line, Transformed | 2 | 2008 | 874 | 0.090 |
Why?
|
| Cyclin D1 | 1 | 2012 | 452 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1127 | 0.090 |
Why?
|
| Regeneration | 1 | 2018 | 1496 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 1896 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1615 | 0.080 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 17591 | 0.080 |
Why?
|
| Valproic Acid | 1 | 2011 | 444 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2003 | 7808 | 0.080 |
Why?
|
| Gene Transfer Techniques | 1 | 2014 | 1204 | 0.080 |
Why?
|
| Mesocricetus | 1 | 2009 | 250 | 0.080 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 3078 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 2012 | 651 | 0.080 |
Why?
|
| Neural Tube | 1 | 2009 | 48 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 8422 | 0.080 |
Why?
|
| Disease Progression | 4 | 2013 | 13405 | 0.080 |
Why?
|
| Osteosarcoma | 1 | 2014 | 888 | 0.080 |
Why?
|
| Cell Separation | 1 | 2014 | 1719 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2408 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 1765 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2842 | 0.080 |
Why?
|
| Mitochondrial Membranes | 1 | 2009 | 171 | 0.080 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 12449 | 0.070 |
Why?
|
| Pentachlorophenol | 1 | 2007 | 10 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2013 | 6234 | 0.070 |
Why?
|
| Phenanthrolines | 1 | 2007 | 51 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 2014 | 878 | 0.070 |
Why?
|
| Rats, Wistar | 3 | 2019 | 1838 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2016 | 1373 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2009 | 1543 | 0.070 |
Why?
|
| Maze Learning | 2 | 2019 | 477 | 0.070 |
Why?
|
| Caspases, Initiator | 1 | 2006 | 31 | 0.070 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2008 | 186 | 0.070 |
Why?
|
| Cytotoxins | 1 | 2007 | 152 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 774 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2051 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2016 | 3908 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2016 | 1618 | 0.060 |
Why?
|
| Meningioma | 1 | 2014 | 1209 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3546 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2009 | 1988 | 0.060 |
Why?
|
| Cricetinae | 1 | 2009 | 2421 | 0.060 |
Why?
|
| Caspase 6 | 2 | 2001 | 15 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3788 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1712 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2014 | 3353 | 0.060 |
Why?
|
| Copper | 1 | 2007 | 368 | 0.060 |
Why?
|
| COS Cells | 1 | 2006 | 1130 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6058 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2015 | 25919 | 0.060 |
Why?
|
| Spinal Cord Injuries | 1 | 2011 | 919 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2004 | 188 | 0.060 |
Why?
|
| Fas Ligand Protein | 1 | 2004 | 213 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 1793 | 0.060 |
Why?
|
| Axons | 1 | 2011 | 1666 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14297 | 0.060 |
Why?
|
| Receptors, Death Domain | 1 | 2003 | 31 | 0.060 |
Why?
|
| RNA Interference | 2 | 2016 | 2842 | 0.060 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2003 | 88 | 0.060 |
Why?
|
| Gene Expression | 2 | 2009 | 7580 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 3755 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2012 | 2905 | 0.050 |
Why?
|
| Weight Loss | 1 | 2014 | 2649 | 0.050 |
Why?
|
| Genotype | 1 | 2017 | 12869 | 0.050 |
Why?
|
| Female | 14 | 2018 | 386085 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2003 | 318 | 0.050 |
Why?
|
| Cell Line, Tumor | 5 | 2018 | 16737 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2006 | 1249 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2012 | 3683 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2015 | 10172 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2511 | 0.050 |
Why?
|
| Proteins | 2 | 2015 | 6015 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2017 | 3471 | 0.050 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2001 | 48 | 0.050 |
Why?
|
| Motor Activity | 1 | 2011 | 2677 | 0.050 |
Why?
|
| Models, Biological | 2 | 2009 | 9449 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2266 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 444 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2017 | 64250 | 0.050 |
Why?
|
| Longevity | 1 | 2008 | 1035 | 0.050 |
Why?
|
| Age Factors | 2 | 2018 | 18298 | 0.050 |
Why?
|
| Complement C5a | 1 | 2000 | 100 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2001 | 814 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 1391 | 0.040 |
Why?
|
| Glycosylation | 1 | 2003 | 1086 | 0.040 |
Why?
|
| Dimerization | 1 | 2001 | 889 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 2750 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2017 | 3585 | 0.040 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2019 | 109 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1248 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2018 | 12061 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2001 | 1649 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 3781 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2661 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 546 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 663 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6501 | 0.030 |
Why?
|
| Nitrobenzoates | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1660 | 0.030 |
Why?
|
| Kinetics | 1 | 2004 | 6352 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 550 | 0.030 |
Why?
|
| Quinazolinones | 1 | 2017 | 224 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2000 | 1216 | 0.030 |
Why?
|
| Phenotype | 1 | 2013 | 16443 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 1977 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2017 | 1757 | 0.030 |
Why?
|
| Vitamin A | 1 | 1998 | 612 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 374 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2007 | 4184 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 612 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2017 | 910 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 802 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3724 | 0.030 |
Why?
|
| Binding Sites | 1 | 2003 | 6028 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2019 | 6331 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3786 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2004 | 2896 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2387 | 0.030 |
Why?
|
| Th1 Cells | 1 | 1998 | 999 | 0.030 |
Why?
|
| Presynaptic Terminals | 1 | 2014 | 301 | 0.030 |
Why?
|
| Middle Aged | 7 | 2018 | 217039 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2004 | 4518 | 0.030 |
Why?
|
| Antigens | 1 | 2017 | 1439 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 4341 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 3590 | 0.020 |
Why?
|
| Inflammation | 1 | 2011 | 10696 | 0.020 |
Why?
|
| Species Specificity | 1 | 2015 | 2404 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1809 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2560 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2017 | 1514 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2017 | 2256 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 3582 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 6112 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2476 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 6137 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2014 | 1160 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2011 | 599 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3554 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 7996 | 0.020 |
Why?
|
| Adult | 5 | 2017 | 216927 | 0.020 |
Why?
|
| Rabbits | 2 | 2006 | 4761 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 23788 | 0.020 |
Why?
|
| Pregnancy | 1 | 2009 | 29441 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 1893 | 0.020 |
Why?
|
| Prognosis | 2 | 2018 | 29337 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 709 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 1690 | 0.020 |
Why?
|
| Sepsis | 1 | 2000 | 2588 | 0.020 |
Why?
|
| Risk | 1 | 2018 | 9613 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2862 | 0.020 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2007 | 430 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5838 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 4067 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 795 | 0.010 |
Why?
|
| Anxiety | 1 | 2019 | 4455 | 0.010 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 2373 | 0.010 |
Why?
|
| Sex Factors | 1 | 2018 | 10457 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5164 | 0.010 |
Why?
|
| Cytokines | 1 | 1998 | 7235 | 0.010 |
Why?
|
| Cell Count | 1 | 2007 | 1832 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2007 | 1735 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12138 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2016 | 6166 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12455 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 980 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2003 | 660 | 0.010 |
Why?
|
| Aging | 1 | 2000 | 8582 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2000 | 122 | 0.010 |
Why?
|
| Histones | 1 | 2011 | 2567 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 1982 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 2000 | 102 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 1286 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2000 | 373 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2011 | 2645 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2007 | 1034 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2000 | 283 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2000 | 572 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2000 | 411 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 35932 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1998 | 362 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 1747 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1998 | 428 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2008 | 2921 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1998 | 817 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 1998 | 376 | 0.010 |
Why?
|
| Oxygen | 1 | 2008 | 4171 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 15647 | 0.010 |
Why?
|
| Glucose | 1 | 2008 | 4343 | 0.010 |
Why?
|
| Organ Size | 1 | 2000 | 2248 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 5699 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1998 | 945 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2000 | 2192 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1998 | 1199 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 9162 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2000 | 2471 | 0.010 |
Why?
|
| Adolescent | 2 | 2014 | 86766 | 0.010 |
Why?
|
| Cell Division | 1 | 1998 | 4446 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 73425 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 166585 | 0.000 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 4474 | 0.000 |
Why?
|
| Young Adult | 1 | 2014 | 57632 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1998 | 5412 | 0.000 |
Why?
|
| Child | 1 | 2014 | 79004 | 0.000 |
Why?
|